153 related articles for article (PubMed ID: 3281365)
1. Comparison of flutamide and Emcyt in hormone-refractory metastatic prostatic cancer.
de Kernion JN; Murphy GP; Priore R
Urology; 1988 Apr; 31(4):312-7. PubMed ID: 3281365
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate.
Johansson JE; Andersson SO; Beckman KW; Lingårdh G; Zador G
Urology; 1987 Jan; 29(1):55-9. PubMed ID: 3798631
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation with long-term follow-up of flutamide and estramustine as initial treatment of metastatic carcinoma of the prostate.
Johansson JE; Andersson SO; Beckman KW; Zador G
Am J Clin Oncol; 1988; 11 Suppl 2():S183-6. PubMed ID: 3242386
[TBL] [Abstract][Full Text] [Related]
4. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
Flamm J; Fischer M
Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
[TBL] [Abstract][Full Text] [Related]
5. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
Benson RC; Gill GM; Cummings KB
Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
[No Abstract] [Full Text] [Related]
6. Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer.
Murphy GP; Huben RP; Priore R
Urology; 1986 Jul; 28(1):36-40. PubMed ID: 3523938
[TBL] [Abstract][Full Text] [Related]
7. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
Benson RC; Wear JB; Gill GM
J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
[TBL] [Abstract][Full Text] [Related]
8. Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900.
Schmidt JD
Prostate; 1984; 5(4):387-99. PubMed ID: 6377283
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
[TBL] [Abstract][Full Text] [Related]
10. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Hauchecorne J
Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
[No Abstract] [Full Text] [Related]
11. A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.
Soloway MS; Beckley S; Brady MF; Chu TM; deKernion JB; Dhabuwala C; Gaeta JF; Gibbons RP; Loening SA; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Murphy GP
J Urol; 1983 Jan; 129(1):56-61. PubMed ID: 6338251
[TBL] [Abstract][Full Text] [Related]
12. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
Benson RC
Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
[No Abstract] [Full Text] [Related]
13. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
Morales A; Nickel JC
Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
[TBL] [Abstract][Full Text] [Related]
14. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Benson RC; Cummings K
Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
[No Abstract] [Full Text] [Related]
15. Clinical toxicity and long-term results of Emcyt therapy for prostate cancer.
Slack NH; Murphy GP
Urology; 1984 Jun; 23(6 Suppl):73-7. PubMed ID: 6375085
[No Abstract] [Full Text] [Related]
16. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
Smith PH; Robinson M; Richards B; Suciu S; De Pauw M; Sylvester R; Denis L
Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
[No Abstract] [Full Text] [Related]
17. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
Nickel CJ; Morales A
Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
[TBL] [Abstract][Full Text] [Related]
18. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
Chisholm GD; O'Donoghue EP; Kennedy CL
Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
[TBL] [Abstract][Full Text] [Related]
19. Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
Loening SA; Beckley S; Brady MF; Chu TM; deKernion JB; Dhabuwala C; Gaeta JF; Gibbons RP; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Soloway MS; Murphy GP
J Urol; 1983 May; 129(5):1001-6. PubMed ID: 6343629
[TBL] [Abstract][Full Text] [Related]
20. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
